Latest News



2018Press Release
12/13/2018
Biological Industries USA Announces Call for Applications for 2019 Stem Cell Research Awards
The 2019 BI-USA Stem Cell Research Awards are designed to encourage cutting-edge scientific research using a variety of cell types that are critical for regenerative medicine applications, including human stem cells (hPSCs and hMSCs), T cells, and endothelial cells.
10/30/2018
Biological Industries USA Adds Human Mesenchymal Cells to its Stem Cell Portfolio in Partnership with StemExpress®
Strategic partnership for the non-exclusive worldwide distribution of StemExpress’ human bone marrow-derived mesenchymal stem cells (BM-MSCs).
06/06/2018
Biological Industries USA Adds Vitronectin XF™ to its Stem Cell Portfolio Through Agreement with Primorigen Biosciences, Inc.
BI-USA has performed extensive evaluation of Vitronectin XF™ in combination with BI’s NutriStem® hPSC Medium, resulting in consistent long-term culture of pluripotent cells in a chemically defined, xeno-free environment.
01/23/2018
Biological Industries USA Announces MSC and Stem Cell Research Award, Including Conference Travel, Laboratory Reagents, and Potential Publicity for Researchers


2017Press Release
12/15/2017
Biological Industries USA announces Growth and Recruitment of New Hires
Connecticut-based cell culture products provider announces new positions as it looks to expand in response of the success of its stem cell reagents and custom media manufacturing business.
05/12/2017
Biological Industries USA To Support Training Programs For Young Scientists Through Partnership With Non-Profit Institute Pathways To Stem Cell Science
Exciting partnership designed to support real-world laboratory skills training in regenerative medicine for early career scientists (high school to college level and beyond).
03/17/2017
Biological Industries USA Signs Agreement with Mill Creek Life Sciences to add PLTMax® Human Platelet Lysate to its Growing Stem Cell Portfolio
Partnership announced for distribution of Human Platelet Lysate, a product derived from human platelets and offers unparalleled cell growth and cytogenetic stability of adult stem cells over fetal bovine serum (FBS). HPL is available in research and clinical grades and has been used in more than 30 clinical trials worldwide, including several Phase III trials.


2016Press Release
11/30/2016
Biological Industries Announces FDA Drug Master File Acceptance For NutriStem hPSC XF Medium
This Drug Master File will enable BI cell therapy customers to integrate NutriStem® hPSC XF Medium into their clinical trial protocols more easily.
06/21/2016
Biological Industries USA to Participate at the International Society for Stem Cell Research Annual Meeting 2016
Announces the launch of new xeno-free endothelial cell culture system suitable for clinical applications.


2015Press Release
10/27/2015
Biological Industries Expands to the United States, Providing Innovative Research Technology to the U.S. Life Sciences Market
BI-USA will focus on high-growth, establishing cell culture training programs, and expanding collaborations within the stem cell and conventional cell culture fields.